Jet injectors have been delivering drugs and vaccines without needles since the Star Trek era, but never caught on widely in real-world medicine.... The needle and syringe are icons of modern medicine ...

Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.

DUBLIN--(BUSINESS WIRE)--The "Needle Free Injection System Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The future of the ...

DUBLIN--(BUSINESS WIRE)--The "Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market" report has been added to ResearchAndMarkets.com's offering. This study ...

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Growth ...

Amherst, N.H. - Long considered a novel technology with limited practical value, needle-free injection (NFI) is attempting to shed its image as an out-of-the-mainstream drug delivery technique. The ...

Growth in Needle-Free Injection System market. Market Dynamics. Some key players. The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 ...

MESA, Ariz., Jan. 23, 2018 /PRNewswire/ -- Premier Distributing, dba LenisUSA.com and Lenis Medical Ltd., announced today an exclusive distribution agreement for the U.S. sales of the LENIS® ...

PharmaJet’s intramuscular (IM) Needle-free Injection System - Stratis ® - was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 ...